相关实验视频

Updated: Jul 18, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

质瘤类干细胞中的PTPRZ1-MET/STAT3/ISG20轴调节与瘤相关的巨细胞极化

Yuxin Wang¹, Jinghao Suo¹, Zhixing Wang¹

¹Department of Molecular Biology and Biochemistry, Medical Primate Research Center, Neuroscience Center, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, China; State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, China.

Cellular signalling

|April 30, 2024

概括

PTPRZ1-MET (ZM) 融合通过增强质瘤干细胞和通过MET-STAT3-ISG20轴促进免疫抑制性瘤相关巨细胞,驱动质瘤向质母细胞进展.

科学领域:

神经瘤学神经瘤学
分子生物学分子生物学
癌症研究癌症研究

背景情况:

PTPRZ1-MET (ZM) 融合与质瘤向多形质母细胞瘤 (GBM) 的进展有关.
在GBM病原体中ZM融合作用的精确机制尚未完全理解.
具有ZM融合的GBM呈现出较差的预后和瘤相关巨细胞 (TAMs) 的增加.

研究的目的:

阐明ZM融合驱动质瘤进展到GBM的机制.
研究ZM融合在质瘤干细胞 (GSCs) 和TAM相互作用中的作用.
在ZM阳性GBM中识别潜在的治疗点.

主要方法:

来自有或没有ZM融合的二次性GBM (sGBM) 患者的RNA-seq数据的分析.
评估GSC的自我更新,扩散和TAM的透/两极分化.
在GSC中调查MET-STAT3-ISG20信号轴.

主要成果:

带有ZM融合的sGBM患者表现出更高的茎度和巨标记物的表达.
ZM融合增强了GSC的自我更新和扩散,加速了质瘤的进展.
阳性ZM的GSCs分泌ISG20,招募TAM并通过MET-STAT3-ISG20轴促进M2类免疫抑制极化.

结论:

在GSC中,ZM融合关键地推动了GBM的启动和通过MET-STAT3-ISG20轴的进展.
由ZM阳性GSCs分泌的细胞外ISG20通过调节TAMs促进瘤进展.
这项研究揭示了ZM阳性GBM的新型致病机制,并突出了潜在的治疗策略.

关键词:

质母细胞瘤 (glioblastoma) 是一个瘤类似干细胞的细胞.在ISG20上,你会看到ISG20.巨细胞是一个巨细胞.这就是PTPRZ1-MET.

更多相关视频

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

Author Spotlight: Patient-Informed 3D Model for Studying Glioblastoma Invasion via Interstitial Fluid Flow

Author Spotlight: Patient-Informed 3D Model for Studying Glioblastoma Invasion via Interstitial Fluid Flow

Published on: October 18, 2024

相关概念视频

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...